DNA damage induction by ionizing radiation

DNA damage induction by ionizing radiation refers to the process in which exposure to ionizing radiation causes various types of lesions in cellular DNA. These include base modifications, single-strand breaks (SSBs), double-strand breaks (DSBs), apurinic/apyrimidinic sites, cross-links between DNA and proteins, and clustered or complex lesions where multiple damages occur close together on the genome[1][3][5]. DSBs are considered the most lethal form of this damage because they can lead to cell death or mutations if not properly repaired[5][7]. The primary cellular response involves activation of signaling cascades that control cell cycle arrest and initiate repair mechanisms such as homologous recombination or non-homologous end joining. Misrepair can result in chromosomal aberrations, gene fusions, deletions, and ultimately carcinogenesis—including leukemia and various solid tumors[1][2][3][5]. Ionizing radiation is not itself a molecular target but rather an external physical agent that induces these effects. Therefore, "DNA damage induction by ionizing radiation" is not considered a therapeutic target like a receptor or enzyme; instead it describes a biological process resulting from exposure to an external factor. This entry is best classified as incorrect for use as a canonical drug target. Key points about this process include: > - Ionizing radiation generates highly reactive species such as hydroxyl radicals that attack biomolecules including DNA. > - Clustered/complex lesions are characteristic signatures of ionizing-radiation–induced genetic injury compared with isolated chemical-induced lesions. > - The persistence or misrepair of these damages underlies increased cancer risk after irradiation—especially in tissues with high proliferation rates or compromised repair capacity. > - Biomarkers like γ-H2AX foci are used experimentally to monitor DSB formation and repair kinetics following irradiation exposure[7]. > - There are no drugs that directly "target" this process; rather some therapies exploit differences in tumor versus normal tissue responses to enhance radiotherapy efficacy while minimizing toxicity[5]. In summary, "DNA damage induction by ionizing radiation" describes an important pathogenic mechanism but does not correspond to a discrete molecular entity suitable for structured drug-target information extraction.

Other names

Radiation-induced DNA damageIR-induced DNA damageIonizing radiation–induced genotoxicity